Treatment of Mitral Regurgitation

 

Female

Male

P

Female

Male

P

Female

Male

P
 
Hofman [15]

Estévez [14]

Attizani [13]

Female patients, n

205

362

<0.0001

64

109

<0.0001

65

106

<0.0001

Age, %

76

72

<0.0001

79

74

0.001

74

71

0.01

EuroSCORE, %

I

24

I

23

0.6

I

19

I

18

0.6

II

8

II

8

0.8

MR aetiology, FMR, %

68

83

0.004

48

58

0.2

75

82

0.3

COPD, %




27

14

0.03

22

22

0.4

Previous MI, %

21

38

<0.0001

20

46

0.001

20

42

0.003

Renal failure, %

34

46

0.007

39

48

0.04

55

43

0.2

Ejection fraction (<40 %), %

37

62

0.007

48

42

0.06

38

34

0.05

Procedural success, %

99

99

0.9

97

98

0.6

98

99

0.6

>1 clip implanted, %

28

46

<0.0001

30

40

0.2

37

48

0.15

1 year overall survival, %

81

82

0.6

79

82

0.8

86

87

0.7



On the other hand, unlike percutaneous aortic stenosis, PMVR includes a wide, various range of patients with MR with different aetiologies in which gender characteristics are differently represented and should not be evaluated as a hole.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 30, 2017 | Posted by in CARDIOLOGY | Comments Off on Treatment of Mitral Regurgitation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access